Evolving interest in meningioma, the most common primary brain tumor, has refined
contemporary management of these tumors. Problematic, however, is the paucity of …

Atypical (WHO grade II) meningiomas occupy an intermediate risk group between benign
(WHO grade I) and anaplastic (WHO grade III) meningiomas. Although grade II …

OBJECTIVE This is the first clinical outcomes report of NRG Oncology RTOG 0539, detailing
the primary endpoint, 3-year progression-free survival (PFS), compared with a predefined …

Although the majority of meningiomas are slow-growing and benign, atypical and anaplastic
meningiomas behave aggressively with a penchant for recurrence. Standard of care …

Object Because of their critical location adjacent to brain, cranial nerve, and vascular
structures, petroclival meningiomas remain a clinical challenge. The authors evaluated …

The treatment of meningiomas is tailored to their histological grade. While World Health
Organization (WHO) grade I lesions can be treated with either surgery or external beam …

The role of radiotherapy (RT) and stereotactic radiosurgery (SRS) as adjuvant or salvage
treatment in high-grade meningiomas (HGM) is still debated. Despite advances in modern …

Atypical and anaplastic meningiomas frequently recur in the relatively short-term after
surgery. We have followed such postoperative cases by short-interval repeated MRI and …

Introduction Atypical meningiomas (World Health Organization [WHO] grade II) represent a
therapeutic challenge given their high recurrence rate and greater mortality compared with …

Atypical meningiomas have poor local control with emerging literature indicating the use of
radiosurgery in treatment. The purpose of this study was to evaluate clinical outcomes …